Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Cash from Investing (Quarterly): -1.354M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.354M |
| June 30, 2023 | -0.078M |
| March 31, 2023 | -0.209M |
| December 31, 2022 | -0.248M |
| September 30, 2022 | -0.602M |
| June 30, 2022 | -0.207M |
| March 31, 2022 | -0.307M |
| December 31, 2021 | -0.369M |
| September 30, 2021 | -0.125M |
| June 30, 2021 | -0.047M |
| March 31, 2021 | -0.893M |
| December 31, 2020 | -0.102M |
| September 30, 2020 | -0.771M |
| June 30, 2020 | -0.023M |
| March 31, 2020 | 1.405M |
| December 31, 2019 | 2.229M |
| September 30, 2019 | -0.407M |
| June 30, 2019 | -0.228M |
| March 31, 2019 | -2.127M |
| December 31, 2018 | -1.026M |
| September 30, 2018 | -2.093M |
| June 30, 2018 | -1.099M |
| March 31, 2018 | -1.028M |
| December 31, 2017 | -0.269M |
| September 30, 2017 | -0.068M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.342M |
| March 31, 2017 | -0.437M |
| September 30, 2016 | -1.182M |
| June 30, 2016 | -1.77M |
| March 31, 2016 | -3.479M |
| December 31, 2015 | -1.75M |
| September 30, 2015 | -3.377M |
| June 30, 2015 | -2.397M |
| March 31, 2015 | -2.438M |
| December 31, 2014 | -0.882M |
| September 30, 2014 | -1.708M |
| June 30, 2014 | -3.473M |
| March 31, 2014 | -2.414M |
| December 31, 2013 | -1.726M |
| September 30, 2013 | -0.572M |
| June 30, 2013 | -1.339M |
| March 31, 2013 | -0.307M |
| December 31, 2012 | -1.038M |
| September 30, 2012 | -1.012M |
| June 30, 2012 | -1.13M |
| March 31, 2012 | -0.948M |
| December 31, 2011 | -0.298M |
| September 30, 2011 | -0.592M |
| June 30, 2011 | -0.461M |
| March 31, 2011 | -0.662M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.354M
Minimum
Sep 2023
2.229M
Maximum
Dec 2019
-0.1298M
Average
-0.2185M
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie Inc | -9.588B |
| Pfizer Inc | -11.00B |
| Johnson & Johnson | -464.00M |
| Merck & Co Inc | 53.00M |
| Cerevel Therapeutics Holdings Inc | -150.21M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.77M |
| Cash from Financing (Quarterly) | 32.13M |
| Free Cash Flow | -199.78M |
| Free Cash Flow Per Share (Quarterly) | 0.0049 |
| Free Cash Flow to Equity (Quarterly) | 1.26M |
| Free Cash Flow to Firm (Quarterly) | 1.416M |